5.
Nishita M, Park S, Nishio T, Kamizaki K, Wang Z, Tamada K
. Ror2 signaling regulates Golgi structure and transport through IFT20 for tumor invasiveness. Sci Rep. 2017; 7(1):1.
PMC: 5428335.
DOI: 10.1038/s41598-016-0028-x.
View
6.
Charan M, Dravid P, Cam M, Setty B, Roberts R, Houghton P
. Tumor secreted ANGPTL2 facilitates recruitment of neutrophils to the lung to promote lung pre-metastatic niche formation and targeting ANGPTL2 signaling affects metastatic disease. Oncotarget. 2020; 11(5):510-522.
PMC: 7007290.
DOI: 10.18632/oncotarget.27433.
View
7.
Copeland B, Bowman M, Boucheix C, Ashman L
. Knockout of the tetraspanin Cd9 in the TRAMP model of de novo prostate cancer increases spontaneous metastases in an organ-specific manner. Int J Cancer. 2013; 133(8):1803-12.
DOI: 10.1002/ijc.28204.
View
8.
Ikeyama S, Koyama M, Yamaoko M, Sasada R, Miyake M
. Suppression of cell motility and metastasis by transfection with human motility-related protein (MRP-1/CD9) DNA. J Exp Med. 1993; 177(5):1231-7.
PMC: 2191011.
DOI: 10.1084/jem.177.5.1231.
View
9.
Kadomatsu T, Endo M, Miyata K, Oike Y
. Diverse roles of ANGPTL2 in physiology and pathophysiology. Trends Endocrinol Metab. 2014; 25(5):245-54.
DOI: 10.1016/j.tem.2014.03.012.
View
10.
Rappa G, Green T, Karbanova J, Corbeil D, Lorico A
. Tetraspanin CD9 determines invasiveness and tumorigenicity of human breast cancer cells. Oncotarget. 2015; 6(10):7970-91.
PMC: 4480729.
DOI: 10.18632/oncotarget.3419.
View
11.
Takano M, Hirose N, Sumi C, Yanoshita M, Nishiyama S, Onishi A
. ANGPTL2 Promotes Inflammation via Integrin α5β1 in Chondrocytes. Cartilage. 2019; 13(2_suppl):885S-897S.
PMC: 8804837.
DOI: 10.1177/1947603519878242.
View
12.
Lananna B, Imai S
. Friends and foes: Extracellular vesicles in aging and rejuvenation. FASEB Bioadv. 2021; 3(10):787-801.
PMC: 8493967.
DOI: 10.1096/fba.2021-00077.
View
13.
Fujii N, Yashiro M, Hatano T, Fujikawa H, Motomura H
. CD9-positive Exosomes Derived from Cancer-associated Fibroblasts Might Inhibit the Proliferation of Malignant Melanoma Cells. Anticancer Res. 2022; 43(1):25-33.
DOI: 10.21873/anticanres.16130.
View
14.
Kubota Y, Oike Y, Satoh S, Tabata Y, Niikura Y, Morisada T
. Cooperative interaction of Angiopoietin-like proteins 1 and 2 in zebrafish vascular development. Proc Natl Acad Sci U S A. 2005; 102(38):13502-7.
PMC: 1224617.
DOI: 10.1073/pnas.0501902102.
View
15.
Takano A, Fukuda T, Shinjo T, Iwashita M, Matsuzaki E, Yamamichi K
. Angiopoietin-like protein 2 is a positive regulator of osteoblast differentiation. Metabolism. 2017; 69:157-170.
DOI: 10.1016/j.metabol.2017.01.006.
View
16.
Tallon C, Picciolini S, Yoo S, Thomas A, Pal A, Alt J
. Inhibition of neutral sphingomyelinase 2 reduces extracellular vesicle release from neurons, oligodendrocytes, and activated microglial cells following acute brain injury. Biochem Pharmacol. 2021; 194:114796.
PMC: 8919377.
DOI: 10.1016/j.bcp.2021.114796.
View
17.
Yin Y, Chen H, Wang Y, Zhang L, Wang X
. Roles of extracellular vesicles in the aging microenvironment and age-related diseases. J Extracell Vesicles. 2021; 10(12):e12154.
PMC: 8491204.
DOI: 10.1002/jev2.12154.
View
18.
Daud A, Kluger H, Kurzrock R, Schimmoller F, Weitzman A, Samuel T
. Phase II randomised discontinuation trial of the MET/VEGF receptor inhibitor cabozantinib in metastatic melanoma. Br J Cancer. 2017; 116(4):432-440.
PMC: 5318966.
DOI: 10.1038/bjc.2016.419.
View
19.
Endo M, Nakano M, Kadomatsu T, Fukuhara S, Kuroda H, Mikami S
. Tumor cell-derived angiopoietin-like protein ANGPTL2 is a critical driver of metastasis. Cancer Res. 2012; 72(7):1784-94.
DOI: 10.1158/0008-5472.CAN-11-3878.
View